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Background:
There is concern that blood pressure lowering in acute stroke may compromise
cerebral perfusion and worsen outcome in the context of carotid stenosis. The
effect of glyceryl trinitrate (GTN) on outcome in acute stroke patients with
carotid stenosis is unclear. We sought to assess GTN’s effect in this context
using data from the Efficacy of Nitric Oxide in Stroke (ENOS) trial.
Methods:
ENOS randomised 4011 patients with acute stroke and raised systolic blood
pressure to transdermal GTN or no GTN within 48 hours of onset. The primary
outcome was the modified Rankin Scale (mRS) at day 90. Ipsilateral carotid
stenosis was split: <30%; 30-50%; 50-70%; >70%. Bilateral carotid stenosis
was split: <30%; 30-50%; >50%. Data are odds ratios (OR) with 95%
confidence intervals (CI) adjusted for baseline prognostic factors.
Results:
2023 (60.5%) ischaemic stroke participants had carotid imaging. Compared with
participants with <30%, >70% ipsilateral stenosis was associated with an
unfavourable shift in mRS at 90 days (OR 1.88, 95% CI 1.44-2.44, p<0.001).
Those with >70% stenosis who received GTN had a favourable shift in mRS (OR
0.56, 95% CI 0.34-0.93, p=0.024) compared to those who received no GTN.
Tendencies towards less dependency, albeit non-significant, were seen in 30-
50% and 50-70% groups. No differences in mRS were seen across groups of
bilateral stenosis or between those who received GTN or not.
Conclusions:
Severe ipsilateral carotid stenosis is associated with poorer functional outcome
at 90 days following ischaemic stroke. GTN appears safe in acute stroke patients
with ipsilateral or bilateral carotid stenosis.
